Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMRT + Carboplatin +/- Fluorouracil in Elderly ESCC
NCT03910634Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of fluorouracil in Esophageal Squamous Cell Carcinoma (ESCC) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Overall objective response rate at 24 months. Status: unknown.
02
Drugs
fluorouracil
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03910634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03910634.